“Evaluating the Sensitivity of (miR-378) as a Circulatory Screening Biomarker for Diabetic Cardiomyopathy: Comparative Study” (2021) Medico Legal Update, 21(1), pp. 912–918. doi:10.37506/mlu.v21i1.2432.